↓ Skip to main content

Dove Medical Press

Asparaginase in the Treatment of Acute Lymphoblastic Leukemia in Adults: Current Evidence and Place in Therapy

Overview of attention for article published in Blood and Lymphatic Cancer: Targets and Therapy, May 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
45 Mendeley
Title
Asparaginase in the Treatment of Acute Lymphoblastic Leukemia in Adults: Current Evidence and Place in Therapy
Published in
Blood and Lymphatic Cancer: Targets and Therapy, May 2022
DOI 10.2147/blctt.s342052
Pubmed ID
Authors

Krishna R Juluri, Chloe Siu, Ryan D Cassaday

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 45 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 9%
Student > Bachelor 4 9%
Student > Master 4 9%
Other 3 7%
Student > Ph. D. Student 2 4%
Other 5 11%
Unknown 23 51%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 6 13%
Medicine and Dentistry 4 9%
Agricultural and Biological Sciences 4 9%
Unspecified 1 2%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 2 4%
Unknown 27 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 February 2024.
All research outputs
#7,493,233
of 25,748,735 outputs
Outputs from Blood and Lymphatic Cancer: Targets and Therapy
#1
of 1 outputs
Outputs of similar age
#143,864
of 448,497 outputs
Outputs of similar age from Blood and Lymphatic Cancer: Targets and Therapy
#1
of 1 outputs
Altmetric has tracked 25,748,735 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 1 research outputs from this source. They receive a mean Attention Score of 4.0. This one scored the same or higher as 0 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,497 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them